Literature DB >> 4119787

Purification of Hodgkin's disease tumor-associated antigens.

D H Katz, S E Order, M Graves, B Benacerraf.   

Abstract

Two antigens that exist in high frequency in tumor tissues of patients with Hodgkin's disease have been obtained in relatively concentrated form. Extracts of Hodgkin's spleen tumor tissue, when subjected to chromatography on Sephadex G-200, separate into three major protein peaks of which only the first (peak I) possesses the predominant antigenic activities associated with the disease. Antigenic analysis performed with hyperimmune rabbit antisera obtained after repeated immunizations with peak I proteins demonstrated that this fraction contained both F and S antigens associated with Hodgkin's disease and small contaminant amounts of an antigen associated with normal lymphocytes. The tissue distribution patterns of the Hodgkin's disease tumor-associated antigens suggest that they both originate in lymphoid tissues and that the F antigen may represent a product of reactive lymphocytes while the S antigen may be a dedifferentiation antigen expressed in very immature lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4119787      PMCID: PMC433268          DOI: 10.1073/pnas.70.2.396

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Cryptococcosis; a review with special reference to apparent association with Hodgkin's disease.

Authors:  B R GENDEL; M ENDE; S L NORMAN
Journal:  Am J Med       Date:  1950-09       Impact factor: 4.965

3.  Hodgkin's disease: evidence for a tumor-associated antigen.

Authors:  S E Order; M Porter; S Hellman
Journal:  N Engl J Med       Date:  1971-08-26       Impact factor: 91.245

4.  Studies of antigens associated with Hodgkin's disease.

Authors:  S E Order; S E Chism; S Hellman
Journal:  Blood       Date:  1972-11       Impact factor: 22.113

5.  Summary of infectious complications occurring in patients with Hodgkin's disease.

Authors:  A R Casazza; C P Duvall; P P Carbone
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

6.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

  6 in total
  4 in total

1.  Increased serum IgD concentrations in patients with Hodgkin's disease.

Authors:  G Corte; M Ferrarini; P Tonda; A Bargellesi
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

2.  A tumor antigen in tissue cultures derived from patients with Hodgkin's disease.

Authors:  J C Long; A C Aisenberg; M V Zamecnik; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

3.  Antigenic analysis of the lymphomata.

Authors:  S E Order
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  Clinical significance of antibodies to ovarian antigens; association with cancer of the genito-urinary tract.

Authors:  A P Forbes; J R Lake; K J Bloch
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.